NDT
@ndt-era.bsky.social
Nephrology Dialysis Transplantation (NDT) is the leading nephrology journal in Europe. NDT is an official journal of the European Renal Association and is published by Oxford University Press.
November 26, 2025 at 3:32 PM
Reposted by NDT
Now online in @ndt-era.bsky.social – this article by Prof Daniel Gale shows how RaDaR data are accelerating drug development for rare kidney diseases – informing NICE appraisals, regulatory endpoints & clinical trials for IgA nephropathy, FSGS, C3G & Alport syndrome.
📄: ow.ly/L9HK50XqqqT
📄: ow.ly/L9HK50XqqqT
November 24, 2025 at 2:44 PM
Now online in @ndt-era.bsky.social – this article by Prof Daniel Gale shows how RaDaR data are accelerating drug development for rare kidney diseases – informing NICE appraisals, regulatory endpoints & clinical trials for IgA nephropathy, FSGS, C3G & Alport syndrome.
📄: ow.ly/L9HK50XqqqT
📄: ow.ly/L9HK50XqqqT
Nephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite Agents
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
Nephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite Agents
Abstract. Anticancer therapies have significantly improved survival rates in patients with cancer; however, despite prophylactic measures, many conventiona
doi.org
November 25, 2025 at 1:34 PM
Nephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite Agents
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
Trends in nephrology: from reducing proteinuria with steroids to curing glomerulonephritis
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
Trends in Nephrology: From reducing proteinuria with steroids to curing glomerulonephritis
Glomerulonephritis (GN) is a subgroup of kidney disorders characterized by inflammation and injury at the glomerular filtration barrier manifesting as hype
doi.org
November 24, 2025 at 12:21 PM
Trends in nephrology: from reducing proteinuria with steroids to curing glomerulonephritis
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox
AbstractBackground. Body roundness index (BRI), an emerging anthropometric measure, has been shown to outperform body mass index (BMI) in predicting mortal
doi.org
November 21, 2025 at 4:00 PM
Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction
Sodium/glucose co-transporter 2 inhibitors (SGLT2i) slow the progression of chronic kidney disease (CKD) and heart failure without the risk of concomitant
doi.org
November 20, 2025 at 10:00 AM
Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
November 18, 2025 at 12:48 PM
November 17, 2025 at 12:11 PM
Recommended calcium intake in adults and children with chronic kidney disease—a European consensus statement
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
November 17, 2025 at 12:08 PM
Recommended calcium intake in adults and children with chronic kidney disease—a European consensus statement
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
Where is the eye of the storm of eGFR formulas?
doi.org/10.1093/ndt/...
The EKFC eGFR equation represents an evolution rather than a revolution, offering better performance and flexibility for broader clinical implementation in Europe
doi.org/10.1093/ndt/...
The EKFC eGFR equation represents an evolution rather than a revolution, offering better performance and flexibility for broader clinical implementation in Europe
November 14, 2025 at 11:26 AM
Where is the eye of the storm of eGFR formulas?
doi.org/10.1093/ndt/...
The EKFC eGFR equation represents an evolution rather than a revolution, offering better performance and flexibility for broader clinical implementation in Europe
doi.org/10.1093/ndt/...
The EKFC eGFR equation represents an evolution rather than a revolution, offering better performance and flexibility for broader clinical implementation in Europe
Reposted by NDT
Life support in hemodialysis emergencies—treatment standard
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Life support in hemodialysis emergencies—treatment standard
ABSTRACT. Hemodialysis removes uremic toxins and excess water and sodium from the blood of patients with kidney failure. For the last 60 years, this techni
academic.oup.com
November 11, 2025 at 2:15 PM
Life support in hemodialysis emergencies—treatment standard
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Reposted by NDT
A novel system to continuously estimate intradialytic blood pressure in real time
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
A novel system to continuously estimate intradialytic blood pressure in real time
ABSTRACTBackground. Intradialytic hypotension (IDH) is a common complication of haemodialysis that is associated with adverse patient outcomes. We have dev
academic.oup.com
November 12, 2025 at 3:08 PM
A novel system to continuously estimate intradialytic blood pressure in real time
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Reposted by NDT
High measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohort
More info:https://academic.oup.com/ndt/article/40/11/2091/8122110
@ndt-era.bsky.social, @hjanders.bsky.social
More info:https://academic.oup.com/ndt/article/40/11/2091/8122110
@ndt-era.bsky.social, @hjanders.bsky.social
High measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohort
ABSTRACTBackground. High glomerular filtration rate (GFR) is generally regarded as beneficial but has been associated with cardiovascular disease (CVD) and
academic.oup.com
November 13, 2025 at 5:30 PM
High measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohort
More info:https://academic.oup.com/ndt/article/40/11/2091/8122110
@ndt-era.bsky.social, @hjanders.bsky.social
More info:https://academic.oup.com/ndt/article/40/11/2091/8122110
@ndt-era.bsky.social, @hjanders.bsky.social
Reposted by NDT
Interesting molecule - Troxerutin as an osmotic agent for PD
academic.oup.com/ndt/advance-...
in @ndt-era.bsky.social
It seems it’s a flavonol from the Japanese pagoda tree en.wikipedia.org/wiki/Troxeru...
#PDSky #NephSky
academic.oup.com/ndt/advance-...
in @ndt-era.bsky.social
It seems it’s a flavonol from the Japanese pagoda tree en.wikipedia.org/wiki/Troxeru...
#PDSky #NephSky
November 13, 2025 at 6:19 PM
Interesting molecule - Troxerutin as an osmotic agent for PD
academic.oup.com/ndt/advance-...
in @ndt-era.bsky.social
It seems it’s a flavonol from the Japanese pagoda tree en.wikipedia.org/wiki/Troxeru...
#PDSky #NephSky
academic.oup.com/ndt/advance-...
in @ndt-era.bsky.social
It seems it’s a flavonol from the Japanese pagoda tree en.wikipedia.org/wiki/Troxeru...
#PDSky #NephSky
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
October 24, 2025 at 9:41 AM
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
Temporal trends in the treatment of relapsing minimal change podocytopathy — a binational cohort study
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
October 21, 2025 at 9:25 AM
Temporal trends in the treatment of relapsing minimal change podocytopathy — a binational cohort study
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
October 21, 2025 at 9:23 AM
Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
October 16, 2025 at 3:07 PM
October 10, 2025 at 1:55 PM
October 9, 2025 at 3:33 PM
Reposted by NDT
Now open access in @ndt-era.bsky.social
Prevalence of Strongyloides stercoralis in HD pts in Vienna
🧐Implementation of targeted screening for S. stercoralis should be considered in pre-KTX protocols in Europe.
▶️ academic.oup.com/ndt/article/...
Prevalence of Strongyloides stercoralis in HD pts in Vienna
🧐Implementation of targeted screening for S. stercoralis should be considered in pre-KTX protocols in Europe.
▶️ academic.oup.com/ndt/article/...
September 28, 2025 at 8:52 AM
Now open access in @ndt-era.bsky.social
Prevalence of Strongyloides stercoralis in HD pts in Vienna
🧐Implementation of targeted screening for S. stercoralis should be considered in pre-KTX protocols in Europe.
▶️ academic.oup.com/ndt/article/...
Prevalence of Strongyloides stercoralis in HD pts in Vienna
🧐Implementation of targeted screening for S. stercoralis should be considered in pre-KTX protocols in Europe.
▶️ academic.oup.com/ndt/article/...
Reposted by NDT
Now online in @ndt-era.bsky.social
Recombinant alpha-1 microglobulin to improve outcomes in survivors of AKI
🧐RMC-035 may improve kidney outcomes in settings characterized by oxidative and ischemia-reperfusion injury.
▶️ academic.oup.com/ndt/article-...
Recombinant alpha-1 microglobulin to improve outcomes in survivors of AKI
🧐RMC-035 may improve kidney outcomes in settings characterized by oxidative and ischemia-reperfusion injury.
▶️ academic.oup.com/ndt/article-...
September 30, 2025 at 2:09 PM
Now online in @ndt-era.bsky.social
Recombinant alpha-1 microglobulin to improve outcomes in survivors of AKI
🧐RMC-035 may improve kidney outcomes in settings characterized by oxidative and ischemia-reperfusion injury.
▶️ academic.oup.com/ndt/article-...
Recombinant alpha-1 microglobulin to improve outcomes in survivors of AKI
🧐RMC-035 may improve kidney outcomes in settings characterized by oxidative and ischemia-reperfusion injury.
▶️ academic.oup.com/ndt/article-...
Reposted by NDT
Review on Renal amyloidosis
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
October 6, 2025 at 3:34 PM
Review on Renal amyloidosis
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
Reposted by NDT
SGLT2 inhibitors in CKD: are they really effective in all patients?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 7, 2025 at 1:15 PM
SGLT2 inhibitors in CKD: are they really effective in all patients?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social